Use of Nonsteroidal Anti-inflammatory Drugs for COVID-19 Infection: Adjunct Therapy?
Cardiol Rev
; 28(6): 303-307, 2020.
Artículo
en Inglés
| MEDLINE | ID: covidwho-970240
ABSTRACT
Severe acute respiratory distress syndrome coronavirus 2 (COVID-19) is the cause of the current pandemic, which remains a tremendous cause of morbidity and mortality worldwide. Although there are numerous trials underway, there is currently no medication known to cure the infection. Nonsteroidal anti-inflammatory drugs (NSAIDs) are inexpensive, widely available medications with antiviral and anti-inflammatory properties and may have utility as an adjunct therapy to improve outcomes in patients with severe COVID-19 infection. A thorough PubMed literature review on the therapeutic use of NSAID was conducted to provide a comprehensive perspective of the role of NSAIDs in treating COVID-19. NSAIDs may be a useful adjunct therapy for patients with severe COVID-19 infection, but further investigation and clinical trials are necessary to ensure their safety and efficacy.
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Neumonía Viral
/
Antiinflamatorios no Esteroideos
/
Infecciones por Coronavirus
/
Betacoronavirus
Tipo de estudio:
Estudio pronóstico
/
Revisiones
Límite:
Humanos
Idioma:
Inglés
Revista:
Cardiol Rev
Asunto de la revista:
Angiología
/
Cardiología
Año:
2020
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS